Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 2
2018 1
2019 1
2020 2
2021 3
2022 5
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study.
Mastorino L, Burzi L, Frigatti G, Fazio A, Celoria V, Macagno N, Rosset F, Passerini SG, Roccuzzo G, Verrone A, Stroppiana E, Ortoncelli M, Dapavo P, Quaglino P, Ribero S. Mastorino L, et al. Among authors: stroppiana e. Expert Opin Biol Ther. 2023 Jul-Dec;23(9):929-936. doi: 10.1080/14712598.2023.2236023. Epub 2023 Jul 17. Expert Opin Biol Ther. 2023. PMID: 37458181
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
Mastorino L, Cariti C, Susca S, Sciamarrelli N, Borriello S, Ortoncelli M, Stroppiana E, Verrone A, Dapavo P, Quaglino P, Ribero S. Mastorino L, et al. Among authors: stroppiana e. Dermatol Ther. 2022 Nov;35(11):e15818. doi: 10.1111/dth.15818. Epub 2022 Sep 22. Dermatol Ther. 2022. PMID: 36097346 No abstract available.
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.
Dapavo P, Siliquini N, Mastorino L, Avallone G, Merli M, Agostini A, Cariti C, Viola R, Stroppiana E, Verrone A, Ortoncelli M, Quaglino P, Ribero S. Dapavo P, et al. Among authors: stroppiana e. J Dermatolog Treat. 2022 Jun;33(4):2352-2357. doi: 10.1080/09546634.2021.1961998. Epub 2021 Aug 13. J Dermatolog Treat. 2022. PMID: 34315331
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.
Roccuzzo G, Mastorino L, Susca S, Cariti C, Passerini SG, Sciamarrelli N, Borriello S, Macagno N, Sliquini N, Avallone G, Verrone A, Stroppiana E, Quaglino P, Ortoncelli M, Dapavo P, Ribero S. Roccuzzo G, et al. Among authors: stroppiana e. Clin Exp Dermatol. 2023 Mar 22;48(4):379-381. doi: 10.1093/ced/llac098. Clin Exp Dermatol. 2023. PMID: 36745578 No abstract available.
Seven Years of Culture Collection of Neisseria gonorrhoeae: Antimicrobial Resistance and Molecular Epidemiology.
Carannante A, Vacca P, Fontana S, Dal Conte I, Ghisetti V, Cusini M, Prignano G, Vocale C, Barbui AM, Stroppiana E, Busetti M, Mencacci A, Rotondi M, De Francesco MA, Bonanno CL, Innocenti P, Latino MA, Riccobono E, Poletti F, Casonato IC, Soldato G, Ambrosio L, Boros S, Ciammaruconi A, Lista F, Stefanelli P. Carannante A, et al. Among authors: stroppiana e. Microb Drug Resist. 2023 Mar;29(3):85-95. doi: 10.1089/mdr.2021.0483. Epub 2023 Feb 8. Microb Drug Resist. 2023. PMID: 36757312 Free PMC article.
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.
De Simone C, Dapavo P, Malagoli P, Martella A, Campanati A, Campione E, Errichetti E, Franchi C, Gambardella A, Megna M, Osti F, Ribero S, Zagni G, Calzavara-Pinton P, Fabbrocini G; PAM Italian Working Group; Amoruso GF, Baglieri F, Biamonte AS, Bianchelli T, Bigi L, Bortoli J, Brunetti B, Buligan C, Cagni E, Calderoni O, Calzavara-Pinton P, Campanati A, Caputo A, Carrera CG, Carugno A, Chersi K, Cicchelli S, De Natale F, De Simone C, Dapavo P, Di Maria D, Errichetti E, Fabbrocini G, Ferrari AS, Fogli E, Forconi R, Franchi C, Galeazzi A, Gambardella A, Giovannini A, Giura MT, Iuculano M, Lazzaretti G, Leporati C, Magnanini M, Malagoli P, Marconi B, Martella A, Maruccia A, Megna M, Miglietta R, Minuti A, Mocci L, Modica S, Narcisi A, Odorici G, Osti F, Pazzaglia M, Peila R, Pertusi G, Pezza M, Pezzullo E, Puccia N, Raulo U, Ribero S, Rossi M, Rusignuolo S, Sapienza G, Savarese C, Scalisi M, Strippoli D, Stroppiana E, Tiberio R, Trischitta A, Tucci MG, Vaira F, Verrone A, Villa L, Zagni F, Zoccali A. De Simone C, et al. Among authors: stroppiana e. Int J Dermatol. 2022 Dec;61(12):1543-1551. doi: 10.1111/ijd.16192. Epub 2022 May 24. Int J Dermatol. 2022. PMID: 35609147 Free PMC article.
20 results